Bausch Health Cos Other Long-Term Assets 2010-2024 | BHC

Bausch Health Cos other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bausch Health Cos Annual Other Long-Term Assets
(Millions of US $)
2023 $307
2022 $326
2021 $340
2020 $664
2019 $411
2018 $109
2017 $111
2016 $2,316
2015 $224
2014 $167
2013 $196
2012 $184
2011 $59
2010 $37
2009 $33
Bausch Health Cos Quarterly Other Long-Term Assets
(Millions of US $)
2024-06-30 $329
2024-03-31 $312
2023-12-31 $307
2023-09-30 $328
2023-06-30 $325
2023-03-31 $318
2022-12-31 $326
2022-09-30 $341
2022-06-30 $338
2022-03-31 $334
2021-12-31 $340
2021-09-30 $343
2021-06-30 $596
2021-03-31 $617
2020-12-31 $664
2020-09-30 $345
2020-06-30 $367
2020-03-31 $411
2019-12-31 $411
2019-09-30 $402
2019-06-30 $360
2019-03-31 $377
2018-12-31 $109
2018-09-30 $108
2018-06-30 $124
2018-03-31 $107
2017-12-31 $111
2017-09-30 $870
2017-06-30 $820
2017-03-31 $1,591
2016-12-31 $2,316
2016-09-30 $214
2016-06-30 $219
2016-03-31 $211
2015-12-31 $224
2015-09-30 $236
2015-06-30 $167
2015-03-31 $171
2014-12-31 $167
2014-09-30 $233
2014-06-30 $206
2014-03-31 $186
2013-12-31 $196
2013-09-30 $242
2013-06-30 $199
2013-03-31 $180
2012-12-31 $184
2012-09-30 $106
2012-06-30 $98
2012-03-31 $87
2011-12-31 $59
2011-09-30 $58
2011-06-30 $54
2011-03-31 $56
2010-12-31 $37
2010-09-30 $28
2010-06-30 $29
2010-03-31 $31
2009-12-31 $33
2009-09-30 $34
2009-06-30 $40
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00